Long-term prevention of erosive or ulcerative gastroesophageal reflux disease relapse with rabeprazole 10 or 20 mg vs. placebo: results of a 5-year study in the United States - Caos, A; Breiter, J; Perdomo, C (Alimentary Pharmacology and Therapeutics, 2005)
et al.